http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H02184674-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_552948600b07278d871438d3f62628d9
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D217-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D495-04
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D217-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D495-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-472
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D209-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-00
filingDate 1989-11-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_750ecdc67965b81d34ea112793b92f4b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_48c457c4e633acf92a7e072adef2c8dc
publicationDate 1990-07-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-H02184674-A
titleOfInvention Novel compound, its production and pharmaceutical composition containing the compound
abstract NEW MATERIAL: A compd. represented by formula I {wherein R is a group represented by formula II [wherein Rx is a heterocyclic group or (substd.) phenyl; R 1 and R 2 are each H, 1-6C alkyl or 2-6C alkenyl or the like; R 3 is H or 1-6C alkyl or the like; R 4 and R 5 are present on C and H or 1-6C alkyl; (m) is 1-3]; R 7 is H, 1-6C alkyl; (n) is 0-2, X is a direct bond, O or S, etc., Y is groups represented by formulae II, III or -S=O; and R 8 and R 9 are each 1-6C alkyl}. n EXAMPLE: 1-(Pyrrolidin-1-yl)methyl-2-[1-oxo-3,4-dihydro(2H)-naphth-6- yl]acetyl-1,2,3,4-tetrahydroisoquinoline hydrochloride. n USE: This new material is used as a medicine and useful for treating vaccine lymph and hyonatremia. n PROCESS: A novel compd. represented by formula V (wherein R 1 '-R 5 ' and R x ' are R 1 -R 5 and R x , respectively) and a compd. represented by formula VI (Y' is Y) are reacted to obtain the compd. represented by formula I wherein R is R 1 '-R 5 ' of formula II and R x ', and Y is Y'). n COPYRIGHT: (C)1990,JPO
priorityDate 1988-11-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394811
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID234781926
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID67834544

Total number of triples: 26.